Tri-Supply
Tri-supply is a joint venture company set up by Gilead Sciences Ltd and Lawrence Laboratories. The company was incorporated in January 2007.
It was set up to produce Atripla which is a combination of Sustiva, manufactured by Lawrence Laboratories and Truvada, manufactured by Gilead Sciences Limited. Atripla is the company’s only product.
It was the first once-daily single tablet regimen for HIV-1 infection intended as a stand-alone therapy or in combination with other antiretrovirals.
Financial Data
-
31st Dec 16 Source: CRO
- €98.3 million turnover
-
€44,242
profit
-
31st Dec 15 Source: CRO
- €172.6 million turnover
-
-€82
profit - 0 employees
- 5 more years available »
Ranking
By Turnover
(€98.3 million)- 472nd in Top Companies
- 50th in Pharma
-
- €98.3 million
Employees
- David Cadogan Director
Latest News
- 4:25am Doyle hotels report no adverse impact from Brexit
- 4:15am Just 33 affordable mortgages drawn down in Dublin city
- 4:00am France faces growing threat of skills shortages
- 2:25am Government had ‘open door’ policy towards NBP bidder, TD claims
- 1:00am Some retirees facing mandatory higher pension drawdowns